Afatinib

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2548 publications

Multi-omics analysis identified SPRR2D as a potential biomarker for tumor prognosis and immune microenvironment infiltration: a pan-cancer perspective.

Multi-omics analysis identified SPRR2D as a potential biomarker for tumor prognosis and immune microenvironment infiltration: a pan-cancer perspective.

Journal: Future science OA

Published: April 04, 2026

Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral Pan-ErbB Receptor Family Blocker Improves Survival in Mice with Bladder Cancer.

Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral Pan-ErbB Receptor Family Blocker Improves Survival in Mice with Bladder Cancer.

Journal: bioRxiv : the preprint server for biology

Published: February 09, 2026

Exploring the potential of heterocyclic-containing tail approach in the development of novel covalent inhibitors dual-targeting EGFR and HER-2: design, synthesis and biological evaluation.

Exploring the potential of heterocyclic-containing tail approach in the development of novel covalent inhibitors dual-targeting EGFR and HER-2: design, synthesis and biological evaluation.

Journal: Bioorganic & medicinal chemistry

Published: February 07, 2026

GARD: Genomic Data based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation.

GARD: Genomic Data based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation.

Journal: bioRxiv : the preprint server for biology

Published: February 06, 2026

Epidermal Growth Factor Receptor (EGFR) atypical mutations in Non-Small-Cell Lung Cancer (NSCLC): 'where the streets have no name'.

Epidermal Growth Factor Receptor (EGFR) atypical mutations in Non-Small-Cell Lung Cancer (NSCLC): 'where the streets have no name'.

Journal: Critical reviews in oncology/hematology

Published: February 03, 2026

A Case of Refractory Pulmonary Enteric Adenocarcinoma with EGFR Sensitive Mutation

A Case of Refractory Pulmonary Enteric Adenocarcinoma with EGFR Sensitive Mutation

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: February 02, 2026

A tri-scale in silico framework integrating pharmacovigilance and mechanistic modeling suggests tepotinib-associated acute kidney injury risk.

A tri-scale in silico framework integrating pharmacovigilance and mechanistic modeling suggests tepotinib-associated acute kidney injury risk.

Journal: Renal failure

Published: January 25, 2026

Surgical Margin Reduction After Immunotargeted Neoadjuvant Therapy in Locally Advanced Hypopharyngeal Carcinoma: A Preliminary Margin Results from neoCHANCE-1 Trial.

Surgical Margin Reduction After Immunotargeted Neoadjuvant Therapy in Locally Advanced Hypopharyngeal Carcinoma: A Preliminary Margin Results from neoCHANCE-1 Trial.

Journal: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale

Published: January 22, 2026

GARD: Genomic Data-Based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation.

GARD: Genomic Data-Based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation.

Journal: Cancers

Published: January 16, 2026

EGFR G719X + S768I co-mutations in NSCLC: genomic landscape and differential responses to EGFR-TKIs in a large real-world cohort.

EGFR G719X + S768I co-mutations in NSCLC: genomic landscape and differential responses to EGFR-TKIs in a large real-world cohort.

Journal: BMC cancer

Published: December 15, 2025

Evaluating the Therapeutic Potential of MRT68921 and Afatinib in Three-Dimensional Models of Epithelial Ovarian Cancer.

Evaluating the Therapeutic Potential of MRT68921 and Afatinib in Three-Dimensional Models of Epithelial Ovarian Cancer.

Journal: Cancers

Published: December 10, 2025

Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers.

Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers.

Journal: Critical reviews in oncology/hematology

Published: December 07, 2025

Showing 1-12 of 2,548

Last Updated: 04/28/2026